ELVN·29337E102·US·equity·Healthcare - Biotechnology-Activist
ELVN (ENLIVEN THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: FMR LLC ($267.7M), Polar Capital Holdings Plc ($198.6M), BlackRock, Inc. ($144.4M). Net institutional sentiment: Bullish.
See how ELVN's score breaks down across 4 SEC sources
Showing 1-20 of 99
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer